Table 1. Patient characteristics of the analysis population formed by PSM.
ARMIN (N = 5033) | Controls(N = 10 039) | Total(N = 15 072) | |
Demographics | |||
– male sex, N (%) | 2231 (44.3) | 4450 (44.3) | 6681 (44.3) |
– age in years, mean ± SD | 72.6 ± 11.6 | 73.7 ± 11.4 | 73.4 ± 11.4 |
Selected comorbidities and clinical characteristics taken from inpatient and outpatient diagnoses in the year before the index date | |||
Elixhauser comorbidity score (17), mean ± SD | 6.3 ± 2.8 | 6.4 ± 3.0 | 6.4 ± 3.0 |
Utilization of the health care system (in the year before the index date) | |||
Number of previous all-cause hospitalizations per patient | |||
– Median (IQR) | 0 (0, 1) | 1 (0, 1) | 1 (0, 1) |
– Mean ± SD | 0.7 ± 1.1 | 1.0 ± 1.5 | 0.9 ± 1.4 |
Number of previous specific* hospitalizations per patient | |||
– Median (IQR) | 0 (0, 0) | 0 (0, 1) | 0 (0, 0) |
– Mean ± SD | 0.3 ± 0.7 | 0.4 ± 0.9 | 0.4 ± 0.8 |
High utilization of outpatient healthcare services, N (%) | 2151 (42.7) | 4283 (42.7) | 6434 (42.7) |
Medication (in the year before the index date) | |||
Number of different ATC codes per patient | |||
– Median (IQR) | 9 (7, 13) | 9 (7, 13) | 9 (7, 13) |
– Mean ± SD | 10.2 ± 4.4 | 10.0 ± 4.8 | 10.1 ± 4.7 |
* Specific hospitalizations were defined as admissions potentially related to adverse drug reactions to currently prescribed drugs, according to Meid et al. 2018 (15) ARMIN,Medicines Initiative Saxony-Thuringia; ATC, Anatomic Therapeutic Chemical classification system; IQR, interquartile range; N, number;
PSM, propensity score matching; SD, standard deviation